Correlation Between Elevation Oncology and Ensysce Biosciences

Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Ensysce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Ensysce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Elevation Oncology and Ensysce Biosciences, you can compare the effects of market volatilities on Elevation Oncology and Ensysce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Ensysce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Ensysce Biosciences.

Diversification Opportunities for Elevation Oncology and Ensysce Biosciences

0.36

Correlation Coefficient

Elevation Oncology  Ensysce Biosciences

Weak diversification

The 3 months correlation between Elevation and Ensysce is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Ensysce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ensysce Biosciences and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Ensysce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ensysce Biosciences has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Ensysce Biosciences go up and down completely randomly.

Pair Corralation between Elevation Oncology and Ensysce Biosciences

Given the investment horizon of 90 days Elevation Oncology is expected to generate 0.81 times more return on investment than Ensysce Biosciences. However, Elevation Oncology is 1.23 times less risky than Ensysce Biosciences. It trades about 0.2 of its potential returns per unit of risk. Ensysce Biosciences is currently generating about 0.13 per unit of risk. If you would invest  65.00  in Elevation Oncology on October 9, 2024 and sell it today you would earn a total of  19.00  from holding Elevation Oncology or generate 29.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Elevation Oncology  vs.  Ensysce Biosciences

Elevation Oncology

Risk-Adjusted Performance

12 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Elevation Oncology are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Elevation Oncology showed solid returns over the last few months and may actually be approaching a breakup point.

Ensysce Biosciences

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ensysce Biosciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Ensysce Biosciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Elevation Oncology and Ensysce Biosciences

The main advantage of trading using opposite Elevation Oncology and Ensysce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Ensysce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensysce Biosciences will offset losses from the drop in Ensysce Biosciences' long position.

The idea behind Elevation Oncology and Ensysce Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.